current glp 1 drugs Poll: in 8 Adults Say They Are Currently Taking a GLP-1 Drug for Weight Loss, Diabetes or Another Condition, Even as Half Say the Are Difficult to Afford New GLP-1 Guidelines for Type
Description
It then develops into a weight disorder called obesity, defined as a BMI 30 kg/m 2 (2)
The effects of dual GLP-1/GIP receptor agonism on glucagon secretion-A review
Be very cautious about OTC products marketed as GLP-1 alternatives most lack clinical evidence
Dr Moses reiterates the long-term view
Lancet 391, 26072618
While mild to moderate nausea is expected with GLP-1 therapy, certain symptoms warrant prompt medical evaluation
